Dipeptidyl peptidase-4 inhibitor for steroid-induced diabetes
| Autor: | Yoshinori Masui, Hiroshi Kaneko, Junwa Kunimatsu, Reo Yoshikawa, Hidekatsu Yanai |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
endocrine system diseases
business.industry Endocrinology Diabetes and Metabolism Dipeptidyl peptidase-4 inhibitor Carbohydrate metabolism Nateglinide Pharmacology medicine.disease Letters To The Editor Metformin Diabetes mellitus Sitagliptin Internal Medicine medicine business Adverse effect Dipeptidyl peptidase-4 medicine.drug |
| Zdroj: | World Journal of Diabetes. 1:99 |
| ISSN: | 1948-9358 |
| DOI: | 10.4239/wjd.v1.i3.99 |
| Popis: | The addition of the dipeptidyl peptidase-4 (DDP-4) inhibitor has been reported to achieve greater improvements in glucose metabolism with fewer adverse events compared to increasing the metformin dose in type 2 diabetic patients. We present a patient with steroid-induced diabetes whose blood glucose levels were ameliorated by the use of the DPP-4 inhibitor, showing that the DPP-4 inhibitors may be an effective and safe oral anti-diabetic drug for steroid-induced diabetes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|